Baird Reiterates an 'Outperform' on Amgen (AMGN); Anticipate a Strong Q212
Tweet Send to a Friend
Baird reiterates an 'Outperform' on Amgen (NASDAQ: AMGN) price target raised to $79.00.
Analyst, Christopher Raymond, said, "Raising our ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Analyst, Christopher Raymond, said, "Raising our ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


